Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons

JAMA. 2007 Apr 18;297(15):1711-3. doi: 10.1001/jama.297.15.1711.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Arginine / analogs & derivatives*
  • Arginine / therapeutic use
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Shock, Cardiogenic / drug therapy*
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Enzyme Inhibitors
  • N(G)-monomethylarginine acetate
  • Vasoconstrictor Agents
  • Arginine
  • Nitric Oxide Synthase